46 Episodo

  1. Uncertainty reigns, but opportunity persists for biotech’s 2025

    Publicado: 7/2/2025
  2. Unlocking Biotech’s Potential: Strategies for Navigating Public and Private Market Investments

    Publicado: 22/11/2024
  3. Former Investor Who Chose Broadcasting Over Biotech ETFs

    Publicado: 30/9/2024
  4. Can AI Solve Molecule Mysteries that will Unlock Simpler Drug Discovery?

    Publicado: 29/8/2024
  5. Shots-on-Goal Licensing Company Aims for Breakthroughs

    Publicado: 19/7/2024
  6. Why Biopharma Needs to Tell Better Stories on Novel Drugs

    Publicado: 11/7/2024
  7. Venture capital velocity: What’s driving renewed momentum in biotech?

    Publicado: 8/7/2024
  8. Pharma Understands Phase One Data – But Does the Market?

    Publicado: 21/6/2024
  9. Davern Capital sees GLP-1 Opportunities Beyond Obesity

    Publicado: 14/6/2024
  10. Betting on Healthcare’s Future Hits – and Misses

    Publicado: 10/6/2024
  11. Innovation and an Aging Population Drive MedTech

    Publicado: 5/6/2024
  12. Biopharma Investors See Opportunities in Targeted Treatments and Gene Editing

    Publicado: 3/6/2024
  13. Biotech with a Mission to Target Unmet Cancer Needs

    Publicado: 31/5/2024
  14. The M&A Pool Set to Accelerate Biotech Innovation

    Publicado: 3/4/2024
  15. How PIPEs finally unblocked biotech’s funding flows

    Publicado: 29/3/2024
  16. Disruptive Forces in Healthcare: Why HCIT is finally set to bounce back

    Publicado: 7/3/2024
  17. Will the Biotech Rebound Run into Pricing Policy Obstacles?

    Publicado: 27/2/2024
  18. Few IPOs but plenty of follow-on for biotech in 2023

    Publicado: 22/1/2024
  19. U.S. Outlook: Will the US economy achieve a soft landing in 2024?

    Publicado: 29/12/2023
  20. Raising Venture Capital: A New Playbook for A New Era in Biotech

    Publicado: 22/11/2023

1 / 3

Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.

Visit the podcast's native language site